Department of Anesthesiology and Pain Medicine, University of Alberta, Edmonton, Alberta, Canada.
Anesthesiology. 2012 Mar;116(3):648-57. doi: 10.1097/ALN.0b013e318247225a.
There is a lack of studies investigating cardioprotection by common combinations of anesthetics. However, because a general anesthetic consists of a mixture of drugs with potentially interfering effects on signaling and cytoprotection, the most favorable combination should be used.
Working rat hearts were exposed to 20 min of ischemia and 30 min of reperfusion. Periischemic sevoflurane (2 vol-%), propofol (10 μM), or remifentanil (3 nM) (single treatments) and the three combinations thereof (combination treatments) were assessed for their ability to improve postischemic left ventricular work and to prevent intracellular Ca leak and overload. Beat-to-beat oscillations in intracellular [Ca] were measured using indo-1 AM. Phosphorylation of calcium/calmodulin-dependent protein kinase IIδ, ryanodine receptor-2, and phospholamban was determined.
The single treatments with sevoflurane or remifentanil were highly protective with respect to functional recovery and Ca overload, but propofol, even at high concentrations, did not show similar protection. Sevoflurane combined with propofol completely lost its protection in the presence of low sedative propofol concentrations (≥1 μM), whereas remifentanil combined with propofol (10 μM) retained its protection. Propofol antagonism of sevoflurane protection was concentration-dependent and mimicked by the reactive oxygen species scavenger N-2-mercaptopropionyl-glycine. Addition of propofol to sevoflurane activated calcium/calmodulin-dependent protein kinase type IIδ and hyperphosphorylated the ryanodine receptor-2, consistent with causing a postischemic Ca leak from the sarcoplasmic reticulum. Remifentanil did not enhance sevoflurane protection.
The choice of anesthetic combination determines the postischemic Ca leak and intracellular overload. The results from these experiments will help to design studies for optimizing perioperative cardioprotection in high-risk surgical patients.
目前缺乏关于常见麻醉药物组合的心脏保护作用的研究。然而,由于全身麻醉由具有潜在干扰信号和细胞保护作用的药物混合物组成,因此应使用最有利的组合。
在缺血前 20 分钟和再灌注 30 分钟期间,用工作心脏暴露于七氟醚(2 体积%)、丙泊酚(10 μM)或瑞芬太尼(3 nM)(单一处理)以及这三种组合(组合处理),以评估其改善缺血后左心室工作的能力,并防止细胞内 Ca 渗漏和过载。使用 indo-1 AM 测量细胞内 Ca 的逐搏振荡。测定钙/钙调蛋白依赖性蛋白激酶 IIδ、兰尼碱受体-2 和磷蛋白的磷酸化。
与功能恢复和 Ca 过载相比,七氟醚或瑞芬太尼的单一处理具有高度保护作用,但丙泊酚即使在高浓度下也没有表现出类似的保护作用。在存在低镇静丙泊酚浓度(≥1 μM)时,七氟醚与丙泊酚的联合完全丧失了其保护作用,而丙泊酚与瑞芬太尼(10 μM)的联合则保留了其保护作用。丙泊酚对七氟醚保护的拮抗作用呈浓度依赖性,并且被活性氧清除剂 N-2-巯基丙酰基甘氨酸模拟。丙泊酚与七氟醚合用可激活钙/钙调蛋白依赖性蛋白激酶 IIδ,并使兰尼碱受体-2过度磷酸化,导致再灌注后肌浆网 Ca 渗漏。瑞芬太尼不能增强七氟醚的保护作用。
麻醉药物组合的选择决定了缺血后的 Ca 渗漏和细胞内过载。这些实验的结果将有助于设计研究,以优化高危手术患者围手术期的心脏保护。